Maria F. Lofiego

Siena, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Transposable elements and homotypic niches drive immune dynamics and resistance in melanoma epigenetic-based immunotherapy.

Transposable elements and homotypic niches drive immune dynamics and resistance in melanoma epigenetic-based immunotherapy.

Journal: Science advances

Published: August 07, 2026

Transposable Elements and Homotypic Niches Drive Immune Dynamics and Resistance in Melanoma Epigenetic-based immunotherapy.

Transposable Elements and Homotypic Niches Drive Immune Dynamics and Resistance in Melanoma Epigenetic-based immunotherapy.

Journal: bioRxiv : the preprint server for biology

Published: November 24, 2025

Circulating EV-microRNAs are dynamic biomarkers of resistance to therapeutic immunomodulation in metastatic melanoma.

Circulating EV-microRNAs are dynamic biomarkers of resistance to therapeutic immunomodulation in metastatic melanoma.

Journal: Communications medicine

Published: August 19, 2025

Integrated multi-omics profiling reveals the role of the DNA methylation landscape in shaping biological heterogeneity and clinical behaviour of metastatic melanoma.

Integrated multi-omics profiling reveals the role of the DNA methylation landscape in shaping biological heterogeneity and clinical behaviour of metastatic melanoma.

Journal: Journal of experimental & clinical cancer research : CR

Published: April 01, 2025

The Immunomodulatory Activity of Thymosin Alpha 1 on Tumor Cell Lines and Distinct Immune Cell Subsets.

The Immunomodulatory Activity of Thymosin Alpha 1 on Tumor Cell Lines and Distinct Immune Cell Subsets.

Journal: OncoTargets and therapy

Published: March 12, 2025

DNA methylation status classifies pleural mesothelioma cells according to their immune profile: implication for precision epigenetic therapy.

DNA methylation status classifies pleural mesothelioma cells according to their immune profile: implication for precision epigenetic therapy.

Journal: Journal of experimental & clinical cancer research : CR

Published: December 24, 2024

Tumor DNA methylation subtypes predict immunotherapy outcomes in pleural mesothelioma patients in the NIBIT-EPI-MESO study.

Tumor DNA methylation subtypes predict immunotherapy outcomes in pleural mesothelioma patients in the NIBIT-EPI-MESO study.

Journal: Nature genetics

Published: September 10, 2024

Epigenetic remodeling to improve the efficacy of immunotherapy in human glioblastoma: pre-clinical evidence for development of new immunotherapy approaches.

Epigenetic remodeling to improve the efficacy of immunotherapy in human glioblastoma: pre-clinical evidence for development of new immunotherapy approaches.

Journal: Journal of translational medicine

Published: December 22, 2023

Immunotherapy of mesothelioma: the evolving change of a long-standing therapeutic dream.

Immunotherapy of mesothelioma: the evolving change of a long-standing therapeutic dream.

Journal: Frontiers in immunology

Published: November 05, 2023

Guadecitabine plus ipilimumab in unresectable melanoma: five-year follow-up and integrated multi-omic analysis in the phase 1b NIBIT-M4 trial.

Guadecitabine plus ipilimumab in unresectable melanoma: five-year follow-up and integrated multi-omic analysis in the phase 1b NIBIT-M4 trial.

Journal: Nature communications

Published: December 22, 2022

Landscape of immune-related signatures induced by targeting of different epigenetic regulators in melanoma: implications for immunotherapy.

Landscape of immune-related signatures induced by targeting of different epigenetic regulators in melanoma: implications for immunotherapy.

Journal: Journal of experimental & clinical cancer research : CR

Published: August 02, 2022

SARS-CoV-2 infection in cancer patients on active therapy after the booster dose of mRNA vaccines.

SARS-CoV-2 infection in cancer patients on active therapy after the booster dose of mRNA vaccines.

Journal: European journal of cancer (Oxford, England : 1990)

Published: March 31, 2022

Showing 1-12 of 20

Last Updated: 09/26/2026